Insider trade

David Portnoy, CEO at Cryo Cell International, bought ~$12K of Cryo Cell International shares.

~$12K
Approx. value · 2,671 sh @ $4.50
126K
Holds after · shares reported
Traded
Aug 15, 2025
Filed
Aug 19, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 14, 2025InsiderCEO purchased ~$24K of CCEL shares in the open market
  2. Aug 15, 2025 · this disclosureInsiderCEO purchased ~$12K of CCEL shares in the open market

What came next

  1. Aug 15, 2025InsiderCEO purchased ~$28K of CCEL shares in the open market
  2. Aug 18, 2025InsiderCEO purchased ~$41K of CCEL shares in the open market
  3. Aug 19, 2025InsiderCEO purchased ~$3.9K of CCEL shares in the open market
  4. Aug 25, 2025Insider · 1 personInsiders: 3 purchases (~$65K)
  5. Aug 26, 2025InsiderCEO purchased ~$49K of CCEL shares in the open market
  6. Aug 27, 2025Insider · 1 personInsiders: 2 purchases (~$62K)
  7. Sep 8, 2025InsiderCEO purchased ~$23K of CCEL shares in the open market
  8. Sep 9, 2025Insider · 1 personInsiders: 4 purchases (~$24K)
  9. Sep 10, 2025Insider · 1 personInsiders: 5 purchases (~$143K)
  10. Sep 16, 2025InsiderCEO purchased ~$29K of CCEL shares in the open market
  11. Sep 17, 2025InsiderCEO purchased ~$25K of CCEL shares in the open market
  12. Sep 18, 2025Insider · 1 personInsiders: 2 purchases (~$23K)
  13. Oct 18, 2025Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cryo Cell International

OQRO holds no insider, Congress, fund or contract record for Cryo Cell International dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CCEL page.

Other recent filings by David Portnoy, Chairman, Co-CEO

The full history of David Portnoy, Chairman, Co-CEO is on the profile page.

How this filing works

Explore the data

Common questions

Which Cryo Cell International (CCEL) insider traded, and how much?

David Portnoy, CEO at Cryo Cell International, bought ~$12K of Cryo Cell International shares. 2,671 shares at $4.50, open market.

When did it happen, and when was it made public?

Traded: Aug 15, 2025. Filed: Aug 19, 2025. That is 4 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

Does this mean CCEL stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Cryo Cell International

Everything OQRO holds on this company is on its CCEL page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data